Ketamine Differentially Attenuates Alcohol Intake in Male Versus Female Alcohol Preferring (P) Rats
- PMID: 29416900
- PMCID: PMC5798244
- DOI: 10.4303/jdar/236030
Ketamine Differentially Attenuates Alcohol Intake in Male Versus Female Alcohol Preferring (P) Rats
Abstract
Background: Although various pharmacological tools in combating addiction to alcohol are available, their efficacy is limited. Hence, there is a critical need for development of more effective medications. Recent advances in the field have identified the glutamatergic system as a potential novel target for intervention in addictive behaviors.
Purpose: Hence, we evaluated the effects of acute administration of low (subanesthetic) doses of ketamine, an NMDA receptor antagonist, on alcohol intake and alcohol preference in both male and female rats.
Study design: Adult alcohol preferring (P) rats were exposed to two-bottle choice (ethanol 10% and water) for at least three weeks following a nine-day training period and the effects of various doses of ketamine (5 mg/kg, 7.5 mg/kg, and 10 mg/kg, injected subcutaneously, SC) on consumption of alcohol over various time periods during a 24 h interval were measured.
Results: Our results indicate that ketamine treatment significantly reduced both alcohol intake and preference in a time- and dose-dependent manner in both sexes. Moreover, a differential sensitivity between the sexes was observed. Thus, although alcohol intake was higher in males, female rats responded much more strongly to the highest dose of ketamine than males in the initial time periods.
Conclusion: It is concluded that glutamatergic receptor manipulations may be of therapeutic potential in addiction to alcohol and that different sexes may respond differentially to such treatments.
Keywords: NMDA receptor; alcohol intake; alcohol preference; alcohol use disorders; glutamate receptors; sex differences.
Conflict of interest statement
Conflict of interest The authors declare that they have no conflict of interest.
Figures


Similar articles
-
Sex and Individual Differences in Alcohol Intake Are Associated with Differences in Ketamine Self-Administration Behaviors and Nucleus Accumbens Dendritic Spine Density.eNeuro. 2019 Dec 4;6(6):ENEURO.0221-19.2019. doi: 10.1523/ENEURO.0221-19.2019. Print 2019 Nov/Dec. eNeuro. 2019. PMID: 31740575 Free PMC article.
-
Both ketamine and NBQX attenuate alcohol drinking in male Wistar rats.Neurosci Lett. 2018 Feb 14;666:175-180. doi: 10.1016/j.neulet.2017.12.055. Epub 2017 Dec 28. Neurosci Lett. 2018. PMID: 29288725 Free PMC article.
-
Sub-anesthetic doses of ketamine attenuate nicotine self-administration in rats.Neurosci Lett. 2018 Mar 6;668:98-102. doi: 10.1016/j.neulet.2018.01.022. Epub 2018 Jan 12. Neurosci Lett. 2018. PMID: 29339170
-
mTOR activation is required for the anti-alcohol effect of ketamine, but not memantine, in alcohol-preferring rats.Behav Brain Res. 2013 Jun 15;247:9-16. doi: 10.1016/j.bbr.2013.02.030. Epub 2013 Mar 4. Behav Brain Res. 2013. PMID: 23466691 Free PMC article.
-
[Interest and mechanisms of action of ketamine in alcohol addiction- A review of clinical and preclinical studies].Biol Aujourdhui. 2023;217(3-4):161-182. doi: 10.1051/jbio/2023028. Epub 2023 Nov 29. Biol Aujourdhui. 2023. PMID: 38018944 Review. French.
Cited by
-
Sex and Individual Differences in Alcohol Intake Are Associated with Differences in Ketamine Self-Administration Behaviors and Nucleus Accumbens Dendritic Spine Density.eNeuro. 2019 Dec 4;6(6):ENEURO.0221-19.2019. doi: 10.1523/ENEURO.0221-19.2019. Print 2019 Nov/Dec. eNeuro. 2019. PMID: 31740575 Free PMC article.
-
Both ketamine and NBQX attenuate alcohol drinking in male Wistar rats.Neurosci Lett. 2018 Feb 14;666:175-180. doi: 10.1016/j.neulet.2017.12.055. Epub 2017 Dec 28. Neurosci Lett. 2018. PMID: 29288725 Free PMC article.
-
Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms.Pharmacol Rep. 2021 Apr;73(2):323-345. doi: 10.1007/s43440-021-00232-4. Epub 2021 Feb 20. Pharmacol Rep. 2021. PMID: 33609274 Free PMC article. Review.
-
Neural Mechanisms Underlying the Rewarding and Therapeutic Effects of Ketamine as a Treatment for Alcohol Use Disorder.Front Behav Neurosci. 2020 Dec 10;14:593860. doi: 10.3389/fnbeh.2020.593860. eCollection 2020. Front Behav Neurosci. 2020. PMID: 33362485 Free PMC article.
-
Acute and chronic glutamate NMDA antagonist treatment attenuates dopamine D1 antagonist-induced reduction of nicotine self-administration in female rats.Pharmacol Biochem Behav. 2024 Jan;234:173678. doi: 10.1016/j.pbb.2023.173678. Epub 2023 Nov 16. Pharmacol Biochem Behav. 2024. PMID: 37979731 Free PMC article.
References
-
- Rammes G, Mahal B, Putzke J, Parsons C, Spielmanns P, Pestel E, et al. The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801. Neuropharmacology. 2001;40:749–760. - PubMed
-
- Popp RL, Lovinger DM. Interaction of acamprosate with ethanol and spermine on NMDA receptors in primary cultured neurons. Eur J Pharmacol. 2000;394:221–231. - PubMed
-
- Leggio L, Addolorato G. Pharmacotherapy of alcohol dependence: past, present and future research. Curr Pharm Des. 2010;16:2074–2075. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources